期刊文献+

载体介导的siRNA抑制TIEG在瘢痕疙瘩成纤维细胞中的表达 被引量:4

Vectored siRNA silences TIEG expression in keloid fibroblast
下载PDF
导出
摘要 目的构建siRNA稳定表达载体,抑制TIEG基因在瘢痕疙瘩成纤维细胞中的表达,为研究TIEG在瘢痕疙瘩等纤维化疾病发生中的作用提供有效的实验工具。方法根据siRNA设计原则设计并合成带有双向启动子具有转录功能的siRNA载体,转入成纤维细胞内,干扰TIEG基因的表达,利用载体可以发荧光观察转染效果,反转录聚合酶链反应(RT-PCR)检测siRNA对TIEG基因的抑制效果。结果瘢痕成纤维细胞经RNAi沉默后TIEGmRNA表达下调。结论成功建立siRNA载体,并在瘢痕疙瘩成纤维细胞中抑制TIEG基因的表达。 Objective To silence the expression of TIEG in keloid fibroblast by stable expression of vectored siRNA and to provide an experiment tool for functional research of TIEG in fibrosis. Methods According to the principles of siRNAdesign, vectored siRNA with bidirectional promoter and transcription function was synthesized, and transfected into keloid fibroblast to silence the expression of TIEG. The effect of transfection was observed with fluorescence.The interference on TIEG mRNA expression was detected by RT-PCR. Results The expression of TIEG mRNA in keloid fibroblast was decreased after RNAi. Conclusion SiRNA vector was constructed successfully and found to be active in silencing of TIEG expression in keloid fibroblasts.
出处 《中国药物与临床》 CAS 2007年第2期106-108,共3页 Chinese Remedies & Clinics
基金 山西省青年科技研究基金资助项目(2006021047)
关键词 RNA干扰 TIEG 瘢痕疙瘩 成纤维细胞 RNAinterference TIEG Keloid Fibroblast
  • 相关文献

参考文献10

  • 1Liu W,Wang DR,Cao YL.TGF-beta:a fibrotic factor in wound scarring and a potential target for anti-scarring gene therapy.Curr Gene Ther,2004,4(1):123-136.
  • 2Chin GS,Liu W,Peled Z,et al.Differential expression of transforming growth factor-beta receptors Ⅰ and Ⅱ and activation Smad3 in keloid fibroblasts.Plast Reconstr Surg,2001,108(2):423 -429.
  • 3Mori Y,Chen SJ,Varga J.Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts.Arthritis Rheum,2003,48(7):1964-1978.
  • 4Yu H,Bock O,Bayat A,et al.Decreased expression of inhibitory SMAD6 and SMAD7 in keloid scarring.J Plast Reconstr Aesthet Surg,2006,59 (3):221-229.
  • 5Tsujita-Kyutoku M,Uehara N,Matsuoka Y,et al.Comparison of transforming growth factor-beta/Smad signaling between normal dermal fibroblasts and fibroblasts derived from central and peripheral areas of keloid lesions.In Vivo,2005,19 (6):959-963.
  • 6Johnsen SA,Subramaniam M,Janknecht R,et al.TGF beta inducible early gene enhances TGF beta/Smad-dependent transcriptional responses.Oncogene,2002,21 (37):5783-5790.
  • 7Johnsen SA,Subramaniam M,Jankecht R,et al.TGF beta inducible early gene enhances TGF beta/Smad-dependent transcriptional responses.Oncogene,2002,21 (37):5783-5790.
  • 8Johnsen SA,Subramaniam M,Katagiri T,et al.Transcriptional regulation of Smad2 is required for enhancement of TGF beta/Smad signaling by TGFbeta inducible early gene.J Cell Biochem,2002,87(2):233-241.
  • 9Shi W,Sun C,He B,et al.GADD34-PP1c recruited by Smad7 dephosphorylates TGF beta type Ⅰ receptor.J Cell Biol,2004,164(2):291-300.
  • 10Koinuma D,Shinozaki M,Komuro A,et al.Arkadia amplifies TGF-beta superfamily signalling through degradation of Smad7.EMBO J,2003,22(24):6458-6470.

同被引文献56

  • 1王春毅,傅仲学.RNA干扰技术在肿瘤基因治疗方面的研究进展[J].国际外科学杂志,2006,33(1):67-70. 被引量:2
  • 2李广帅,陈言汤,牛扶幼,刘林嶓.病理性瘢痕组织中survivin mRNA和C-myc、P27^(kip1)蛋白的表达[J].郑州大学学报(医学版),2006,41(6):1030-1033. 被引量:4
  • 3Altieri DC. Validating survivin as a cancer therapeutic target[ J]. Nat Rev Cancer, 2003, 3( 1 ) :46-54.
  • 4Ma H, Nguyen C, Lee KS, et al. Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression [ J ]. Oncogene, 2005, 24 (22) :3619-3631.
  • 5Tsuruma T, Hata F, Torigoe T, et al. Phase I clinical study of antiapoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer [ J ]. J Transl Med, 2004, 2(1):19.
  • 6Ma H, Nguyen C, Lee KS, et al. Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression[J]. Oncogene, 2005, 24(22):3619-3631.
  • 7Sun C, Nettesheim D, Liu Z, et al. Solution structure of human survivin and its binding interface with Smac/Diablo[ J]. Biochemistry, 2005, 44(1) :11-17.
  • 8Li F. Role of survivin and its splice variants in tumorigenesis[J]. Br J Cancer, 2005, 92(2) :212-216.
  • 9Castedo M, Perfettini JL, Roumier T, et al. Cell death by mitotic catastrophe : a molecular definition [ J ]. Oncogene, 2004, 23 (16) :2825-2837.
  • 10Colnaghi R, Connell CM, Barrett RM, et al. Separating the antiapoptotic and mitotic roles of survivin [ J ]. J Biol Chem, 2006, 281 (44) :33450-33456.

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部